Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 78 entries
Sorted by: Best Match Show Resources per page
14 Years after Discovery: Clinical Follow-up on 15 Patients with Inducible Co-Stimulator Deficiency.

Frontiers in immunology

Schepp J, Chou J, Skrabl-Baumgartner A, Arkwright PD, Engelhardt KR, Hambleton S, Morio T, Röther E, Warnatz K, Geha R, Grimbacher B.
PMID: 28861081
Front Immunol. 2017 Aug 16;8:964. doi: 10.3389/fimmu.2017.00964. eCollection 2017.

BACKGROUND: Inducible co-stimulator (ICOS) deficiency was the first monogenic defect reported to cause common variable immunodeficiency (CVID)-like disease in 2003. Since then, 16 patients have been reported worldwide with an increasing range of clinical phenotypes.OBJECTIVE: We sought to compare...

Cite
Schepp J, Chou J, Skrabl-Baumgartner A, et al. 14 Years after Discovery: Clinical Follow-up on 15 Patients with Inducible Co-Stimulator Deficiency. Front Immunol. 2017;8:964doi: 10.3389/fimmu.2017.00964.
Schepp, J., Chou, J., Skrabl-Baumgartner, A., Arkwright, P. D., Engelhardt, K. R., Hambleton, S., Morio, T., Röther, E., Warnatz, K., Geha, R., & Grimbacher, B. (2017). 14 Years after Discovery: Clinical Follow-up on 15 Patients with Inducible Co-Stimulator Deficiency. Frontiers in immunology, 8964. https://doi.org/10.3389/fimmu.2017.00964
Schepp, Johanna, et al. "14 Years after Discovery: Clinical Follow-up on 15 Patients with Inducible Co-Stimulator Deficiency." Frontiers in immunology vol. 8 (2017): 964. doi: https://doi.org/10.3389/fimmu.2017.00964
Schepp J, Chou J, Skrabl-Baumgartner A, Arkwright PD, Engelhardt KR, Hambleton S, Morio T, Röther E, Warnatz K, Geha R, Grimbacher B. 14 Years after Discovery: Clinical Follow-up on 15 Patients with Inducible Co-Stimulator Deficiency. Front Immunol. 2017 Aug 16;8:964. doi: 10.3389/fimmu.2017.00964. eCollection 2017. PMID: 28861081; PMCID: PMC5561331.
Copy Download .nbib Format: NLM
Ruthenium Oxidase Catalysis for Site-Selective C-H Alkenylations with Ambient O2 as the Sole Oxidant.

Angewandte Chemie (International ed. in English)

Bechtoldt A, Tirler C, Raghuvanshi K, Warratz S, Kornhaaß C, Ackermann L.
PMID: 26489871
Angew Chem Int Ed Engl. 2016 Jan 04;55(1):264-7. doi: 10.1002/anie.201507801. Epub 2015 Oct 22.

Ruthenium(II) oxidase catalysis by direct dioxygen-coupled turnover enabled step-economical oxidative C-H alkenylation reactions at ambient pressure. Versatile ruthenium(II) biscarboxylate catalysts displayed ample substrate scope and proved applicable to weakly coordinating and removable directing groups. The twofold C-H functionalization strategy...

Cite
Bechtoldt A, Tirler C, Raghuvanshi K, et al. Ruthenium Oxidase Catalysis for Site-Selective C-H Alkenylations with Ambient O2 as the Sole Oxidant. Angew Chem Int Ed Engl. 2015;55(1):264-7doi: 10.1002/anie.201507801.
Bechtoldt, A., Tirler, C., Raghuvanshi, K., Warratz, S., Kornhaaß, C., & Ackermann, L. (2016). Ruthenium Oxidase Catalysis for Site-Selective C-H Alkenylations with Ambient O2 as the Sole Oxidant. Angewandte Chemie (International ed. in English), 55(1), 264-7. https://doi.org/10.1002/anie.201507801
Bechtoldt, Alexander, et al. "Ruthenium Oxidase Catalysis for Site-Selective C-H Alkenylations with Ambient O2 as the Sole Oxidant." Angewandte Chemie (International ed. in English) vol. 55,1 (2016): 264-7. doi: https://doi.org/10.1002/anie.201507801
Bechtoldt A, Tirler C, Raghuvanshi K, Warratz S, Kornhaaß C, Ackermann L. Ruthenium Oxidase Catalysis for Site-Selective C-H Alkenylations with Ambient O2 as the Sole Oxidant. Angew Chem Int Ed Engl. 2016 Jan 04;55(1):264-7. doi: 10.1002/anie.201507801. Epub 2015 Oct 22. PMID: 26489871.
Copy Download .nbib Format: NLM
Numerical studies of the heterogeneous combustion of char using detailed chemistry.

Chemosphere

Miessen G, Behrendt F, Deutschmann O, Warnatz J.
PMID: 11219686
Chemosphere. 2001 Feb-Mar;42(5):609-13. doi: 10.1016/s0045-6535(00)00234-4.

The oxidation of graphite is used as a model system for the combustion of char. In order to understand this oxidation process a stagnation-point flow of an oxygen stream on a graphite surface is investigated numerically. The chemical reactions...

Cite
Miessen G, Behrendt F, Deutschmann O, et al. Numerical studies of the heterogeneous combustion of char using detailed chemistry. Chemosphere. 2001;42(5):609-13doi: 10.1016/s0045-6535(00)00234-4.
Miessen, G., Behrendt, F., Deutschmann, O., & Warnatz, J. (2001). Numerical studies of the heterogeneous combustion of char using detailed chemistry. Chemosphere, 42(5), 609-13. https://doi.org/10.1016/s0045-6535(00)00234-4
Miessen, G, et al. "Numerical studies of the heterogeneous combustion of char using detailed chemistry." Chemosphere vol. 42,5 (2001): 609-13. doi: https://doi.org/10.1016/s0045-6535(00)00234-4
Miessen G, Behrendt F, Deutschmann O, Warnatz J. Numerical studies of the heterogeneous combustion of char using detailed chemistry. Chemosphere. 2001 Feb-Mar;42(5):609-13. doi: 10.1016/s0045-6535(00)00234-4. PMID: 11219686.
Copy Download .nbib Format: NLM
Competitive adsorption of NO, NO2, CO2, and H2O on BaO(100): a quantum chemical study.

The journal of physical chemistry. B

Tutuianu M, Inderwildi OR, Bessler WG, Warnatz J.
PMID: 16942088
J Phys Chem B. 2006 Sep 07;110(35):17484-92. doi: 10.1021/jp055268x.

Density functional theory (DFT) quantum chemical calculations are used to determine adsorption energies and geometries of NO, NO(2), CO(2), and H(2)O on a barium oxide (100) surface. The study includes two adsorption geometries for NO(2). All species form thermodynamically...

Cite
Tutuianu M, Inderwildi OR, Bessler WG, et al. Competitive adsorption of NO, NO2, CO2, and H2O on BaO(100): a quantum chemical study. J Phys Chem B. 2006;110(35):17484-92doi: 10.1021/jp055268x.
Tutuianu, M., Inderwildi, O. R., Bessler, W. G., & Warnatz, J. (2006). Competitive adsorption of NO, NO2, CO2, and H2O on BaO(100): a quantum chemical study. The journal of physical chemistry. B, 110(35), 17484-92. https://doi.org/10.1021/jp055268x
Tutuianu, Monica, et al. "Competitive adsorption of NO, NO2, CO2, and H2O on BaO(100): a quantum chemical study." The journal of physical chemistry. B vol. 110,35 (2006): 17484-92. doi: https://doi.org/10.1021/jp055268x
Tutuianu M, Inderwildi OR, Bessler WG, Warnatz J. Competitive adsorption of NO, NO2, CO2, and H2O on BaO(100): a quantum chemical study. J Phys Chem B. 2006 Sep 07;110(35):17484-92. doi: 10.1021/jp055268x. PMID: 16942088.
Copy Download .nbib Format: NLM
Astronomical League (D2).

Science (New York, N.Y.)

Garnatz W.
PMID: 17741765
Science. 1958 Feb 21;127(3295):412. doi: 10.1126/science.127.3295.412-b.

No abstract available.

Cite
Garnatz W. Astronomical League (D2). Science. 1958;127(3295):412doi: 10.1126/science.127.3295.412-b.
Garnatz, W. (1958). Astronomical League (D2). Science (New York, N.Y.), 127(3295), 412. https://doi.org/10.1126/science.127.3295.412-b
Garnatz, W. "Astronomical League (D2)." Science (New York, N.Y.) vol. 127,3295 (1958): 412. doi: https://doi.org/10.1126/science.127.3295.412-b
Garnatz W. Astronomical League (D2). Science. 1958 Feb 21;127(3295):412. doi: 10.1126/science.127.3295.412-b. PMID: 17741765.
Copy Download .nbib Format: NLM
Electronic structure and absorption spectra of biferrocenyl and bisfulvalenide diiron radical cations: detection and assignment of new low-energy transitions.

Chemistry (Weinheim an der Bergstrasse, Germany)

Warratz R, Aboulfadl H, Bally T, Tuczek F.
PMID: 19130525
Chemistry. 2009;15(7):1604-17. doi: 10.1002/chem.200801054.

UV-visible/near-IR (NIR)/mid-IR (MIR) solution, solid-state, and matrix-isolation electronic absorption spectra of the Fe(II)-Fe(III) mixed-valent homobimetallic compounds biferrocenyl triiodide (1) and 1',1'''-diethylbiferrocenyltriiodide (2) reveal the presence of a low-energy transition in the MIR region that has not been reported before....

Cite
Warratz R, Aboulfadl H, Bally T, et al. Electronic structure and absorption spectra of biferrocenyl and bisfulvalenide diiron radical cations: detection and assignment of new low-energy transitions. Chemistry. 2009;15(7):1604-17doi: 10.1002/chem.200801054.
Warratz, R., Aboulfadl, H., Bally, T., & Tuczek, F. (2009). Electronic structure and absorption spectra of biferrocenyl and bisfulvalenide diiron radical cations: detection and assignment of new low-energy transitions. Chemistry (Weinheim an der Bergstrasse, Germany), 15(7), 1604-17. https://doi.org/10.1002/chem.200801054
Warratz, Ralf, et al. "Electronic structure and absorption spectra of biferrocenyl and bisfulvalenide diiron radical cations: detection and assignment of new low-energy transitions." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 15,7 (2009): 1604-17. doi: https://doi.org/10.1002/chem.200801054
Warratz R, Aboulfadl H, Bally T, Tuczek F. Electronic structure and absorption spectra of biferrocenyl and bisfulvalenide diiron radical cations: detection and assignment of new low-energy transitions. Chemistry. 2009;15(7):1604-17. doi: 10.1002/chem.200801054. PMID: 19130525.
Copy Download .nbib Format: NLM
Arene-Ligand-Free Ruthenium(II/III) Manifold for meta-C-H Alkylation: Remote Purine Diversification.

Chemistry (Weinheim an der Bergstrasse, Germany)

Fumagalli F, Warratz S, Zhang SK, Rogge T, Zhu C, Stückl AC, Ackermann L.
PMID: 29406613
Chemistry. 2018 Mar 15;24(16):3984-3988. doi: 10.1002/chem.201800530. Epub 2018 Feb 21.

meta-Selective C-H alkylations of bioactive purine derivatives were accomplished by versatile ruthenium catalysis. Thus, the arene-ligand-free complex [Ru(OAc)

Cite
Fumagalli F, Warratz S, Zhang SK, et al. Arene-Ligand-Free Ruthenium(II/III) Manifold for meta-C-H Alkylation: Remote Purine Diversification. Chemistry. 2018;24(16):3984-3988doi: 10.1002/chem.201800530.
Fumagalli, F., Warratz, S., Zhang, S. K., Rogge, T., Zhu, C., Stückl, A. C., & Ackermann, L. (2018). Arene-Ligand-Free Ruthenium(II/III) Manifold for meta-C-H Alkylation: Remote Purine Diversification. Chemistry (Weinheim an der Bergstrasse, Germany), 24(16), 3984-3988. https://doi.org/10.1002/chem.201800530
Fumagalli, Fernando, et al. "Arene-Ligand-Free Ruthenium(II/III) Manifold for meta-C-H Alkylation: Remote Purine Diversification." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 24,16 (2018): 3984-3988. doi: https://doi.org/10.1002/chem.201800530
Fumagalli F, Warratz S, Zhang SK, Rogge T, Zhu C, Stückl AC, Ackermann L. Arene-Ligand-Free Ruthenium(II/III) Manifold for meta-C-H Alkylation: Remote Purine Diversification. Chemistry. 2018 Mar 15;24(16):3984-3988. doi: 10.1002/chem.201800530. Epub 2018 Feb 21. PMID: 29406613.
Copy Download .nbib Format: NLM
Diverging views on health information exchange organizations.

Learning health systems

Vest JR, Greenberger MF, Garnatz A.
PMID: 31245563
Learn Health Syst. 2017 Jun 12;1(3):e10031. doi: 10.1002/lrh2.10031. eCollection 2017 Jul.

INTRODUCTION: Health information exchange (HIE) capabilities meet the demands for a more effective, efficient, and safer health care system. However, organizations and individual providers have pursued different strategies to meet their respective needs for HIE capabilities. Because effective information...

Cite
Vest JR, Greenberger MF, Garnatz A. Diverging views on health information exchange organizations. Learn Health Syst. 2017;1(3):e10031doi: 10.1002/lrh2.10031.
Vest, J. R., Greenberger, M. F., & Garnatz, A. (2017). Diverging views on health information exchange organizations. Learning health systems, 1(3), e10031. https://doi.org/10.1002/lrh2.10031
Vest, Joshua R, et al. "Diverging views on health information exchange organizations." Learning health systems vol. 1,3 (2017): e10031. doi: https://doi.org/10.1002/lrh2.10031
Vest JR, Greenberger MF, Garnatz A. Diverging views on health information exchange organizations. Learn Health Syst. 2017 Jun 12;1(3):e10031. doi: 10.1002/lrh2.10031. eCollection 2017 Jul. PMID: 31245563; PMCID: PMC6508502.
Copy Download .nbib Format: NLM
An atypical case of pediatric epidermolysis bullosa acquisita: Review of diagnosis and pitfalls.

JAAD case reports

Patel A, Wanat K, Lalor L.
PMID: 33665285
JAAD Case Rep. 2021 Jan 20;9:81-85. doi: 10.1016/j.jdcr.2021.01.005. eCollection 2021 Mar.

No abstract available.

Cite
Patel A, Wanat K, Lalor L. An atypical case of pediatric epidermolysis bullosa acquisita: Review of diagnosis and pitfalls. JAAD Case Rep. 2021;9:81-85doi: 10.1016/j.jdcr.2021.01.005.
Patel, A., Wanat, K., & Lalor, L. (2021). An atypical case of pediatric epidermolysis bullosa acquisita: Review of diagnosis and pitfalls. JAAD case reports, 981-85. https://doi.org/10.1016/j.jdcr.2021.01.005
Patel, Ashaki, et al. "An atypical case of pediatric epidermolysis bullosa acquisita: Review of diagnosis and pitfalls." JAAD case reports vol. 9 (2021): 81-85. doi: https://doi.org/10.1016/j.jdcr.2021.01.005
Patel A, Wanat K, Lalor L. An atypical case of pediatric epidermolysis bullosa acquisita: Review of diagnosis and pitfalls. JAAD Case Rep. 2021 Jan 20;9:81-85. doi: 10.1016/j.jdcr.2021.01.005. eCollection 2021 Mar. PMID: 33665285; PMCID: PMC7902999.
Copy Download .nbib Format: NLM
Rubella vaccine-induced granulomas are a novel phenotype with incomplete penetrance of genetic defects in cytotoxicity.

The Journal of allergy and clinical immunology

Groß M, Speckmann C, May A, Gajardo-Carrasco T, Wustrau K, Maier SL, Panning M, Huzly D, Agaimy A, Bryceson YT, Choo S, Chow CW, Dückers G, Fasth A, Fraitag S, Gräwe K, Haxelmans S, Holzinger D, Hudowenz O, Hübschen JM, Khurana C, Kienle K, Klifa R, Korn K, Kutzner H, Lämmermann T, Ledig S, Lipsker D, Meeths M, Naumann-Bartsch N, Rascon J, Schänzer A, Seidl M, Tesi B, Vauloup-Fellous C, Vollmer-Kary B, Warnatz K, Wehr C, Neven B, Vargas P, Sepulveda FE, Lehmberg K, Schmitt-Graeff A, Ehl S.
PMID: 34033843
J Allergy Clin Immunol. 2022 Jan;149(1):388-399.e4. doi: 10.1016/j.jaci.2021.05.007. Epub 2021 May 24.

BACKGROUND: Rubella virus-induced granulomas have been described in patients with various inborn errors of immunity. Most defects impair T-cell immunity, suggesting a critical role of T cells in rubella elimination. However, the molecular mechanism of virus control remains elusive.OBJECTIVE:...

Cite
Groß M, Speckmann C, May A, et al. Rubella vaccine-induced granulomas are a novel phenotype with incomplete penetrance of genetic defects in cytotoxicity. J Allergy Clin Immunol. 2021;149(1):388-399.e4doi: 10.1016/j.jaci.2021.05.007.
Groß, M., Speckmann, C., May, A., Gajardo-Carrasco, T., Wustrau, K., Maier, S. L., Panning, M., Huzly, D., Agaimy, A., Bryceson, Y. T., Choo, S., Chow, C. W., Dückers, G., Fasth, A., Fraitag, S., Gräwe, K., Haxelmans, S., Holzinger, D., Hudowenz, O., Hübschen, J. M., Khurana, C., Kienle, K., Klifa, R., Korn, K., Kutzner, H., Lämmermann, T., Ledig, S., Lipsker, D., Meeths, M., Naumann-Bartsch, N., Rascon, J., Schänzer, A., Seidl, M., Tesi, B., Vauloup-Fellous, C., Vollmer-Kary, B., Warnatz, K., Wehr, C., Neven, B., Vargas, P., Sepulveda, F. E., Lehmberg, K., Schmitt-Graeff, A., & Ehl, S. (2022). Rubella vaccine-induced granulomas are a novel phenotype with incomplete penetrance of genetic defects in cytotoxicity. The Journal of allergy and clinical immunology, 149(1), 388-399.e4. https://doi.org/10.1016/j.jaci.2021.05.007
Groß, Miriam, et al. "Rubella vaccine-induced granulomas are a novel phenotype with incomplete penetrance of genetic defects in cytotoxicity." The Journal of allergy and clinical immunology vol. 149,1 (2022): 388-399.e4. doi: https://doi.org/10.1016/j.jaci.2021.05.007
Groß M, Speckmann C, May A, Gajardo-Carrasco T, Wustrau K, Maier SL, Panning M, Huzly D, Agaimy A, Bryceson YT, Choo S, Chow CW, Dückers G, Fasth A, Fraitag S, Gräwe K, Haxelmans S, Holzinger D, Hudowenz O, Hübschen JM, Khurana C, Kienle K, Klifa R, Korn K, Kutzner H, Lämmermann T, Ledig S, Lipsker D, Meeths M, Naumann-Bartsch N, Rascon J, Schänzer A, Seidl M, Tesi B, Vauloup-Fellous C, Vollmer-Kary B, Warnatz K, Wehr C, Neven B, Vargas P, Sepulveda FE, Lehmberg K, Schmitt-Graeff A, Ehl S. Rubella vaccine-induced granulomas are a novel phenotype with incomplete penetrance of genetic defects in cytotoxicity. J Allergy Clin Immunol. 2022 Jan;149(1):388-399.e4. doi: 10.1016/j.jaci.2021.05.007. Epub 2021 May 24. PMID: 34033843.
Copy Download .nbib Format: NLM
Therapeutic options for CTLA-4 insufficiency.

The Journal of allergy and clinical immunology

Egg D, Rump IC, Mitsuiki N, Rojas-Restrepo J, Maccari ME, Schwab C, Gabrysch A, Warnatz K, Goldacker S, Patiño V, Wolff D, Okada S, Hayakawa S, Shikama Y, Kanda K, Imai K, Sotomatsu M, Kuwashima M, Kamiya T, Morio T, Matsumoto K, Mori T, Yoshimoto Y, Dybedal I, Kanariou M, Kucuk ZY, Chapdelaine H, Petruzelkova L, Lorenz HM, Sullivan KE, Heimall J, Moutschen M, Litzman J, Recher M, Albert MH, Hauck F, Seneviratne S, Pachlopnik Schmid J, Kolios A, Unglik G, Klemann C, Snapper S, Giulino-Roth L, Svaton M, Platt CD, Hambleton S, Neth O, Gosse G, Reinsch S, Holzinger D, Kim YJ, Bakhtiar S, Atschekzei F, Schmidt R, Sogkas G, Chandrakasan S, Rae W, Derfalvi B, Marquart HV, Ozen A, Kiykim A, Karakoc-Aydiner E, Králíčková P, de Bree G, Kiritsi D, Seidel MG, Kobbe R, Dantzer J, Alsina L, Armangue T, Lougaris V, Agyeman P, Nyström S, Buchbinder D, Arkwright PD, Grimbacher B.
PMID: 34111452
J Allergy Clin Immunol. 2021 Jun 07; doi: 10.1016/j.jaci.2021.04.039. Epub 2021 Jun 07.

BACKGROUND: Heterozygous germline mutations in cytotoxic T lymphocyte-associated antigen-4 (CTLA4) impair the immunomodulatory function of regulatory T cells. Affected individuals are prone to life-threatening autoimmune and lymphoproliferative complications. A number of therapeutic options are currently being used with variable...

Cite
Egg D, Rump IC, Mitsuiki N, et al. Therapeutic options for CTLA-4 insufficiency. J Allergy Clin Immunol. 2021;doi: 10.1016/j.jaci.2021.04.039.
Egg, D., Rump, I. C., Mitsuiki, N., Rojas-Restrepo, J., Maccari, M. E., Schwab, C., Gabrysch, A., Warnatz, K., Goldacker, S., Patiño, V., Wolff, D., Okada, S., Hayakawa, S., Shikama, Y., Kanda, K., Imai, K., Sotomatsu, M., Kuwashima, M., Kamiya, T., Morio, T., Matsumoto, K., Mori, T., Yoshimoto, Y., Dybedal, I., Kanariou, M., Kucuk, Z. Y., Chapdelaine, H., Petruzelkova, L., Lorenz, H. M., Sullivan, K. E., Heimall, J., Moutschen, M., Litzman, J., Recher, M., Albert, M. H., Hauck, F., Seneviratne, S., Pachlopnik Schmid, J., Kolios, A., Unglik, G., Klemann, C., Snapper, S., Giulino-Roth, L., Svaton, M., Platt, C. D., Hambleton, S., Neth, O., Gosse, G., Reinsch, S., Holzinger, D., Kim, Y. J., Bakhtiar, S., Atschekzei, F., Schmidt, R., Sogkas, G., Chandrakasan, S., Rae, W., Derfalvi, B., Marquart, H. V., Ozen, A., Kiykim, A., Karakoc-Aydiner, E., Králíčková, P., de Bree, G., Kiritsi, D., Seidel, M. G., Kobbe, R., Dantzer, J., Alsina, L., Armangue, T., Lougaris, V., Agyeman, P., Nyström, S., Buchbinder, D., Arkwright, P. D., & Grimbacher, B. (2021). Therapeutic options for CTLA-4 insufficiency. The Journal of allergy and clinical immunology, . https://doi.org/10.1016/j.jaci.2021.04.039
Egg, David, et al. "Therapeutic options for CTLA-4 insufficiency." The Journal of allergy and clinical immunology vol. (2021). doi: https://doi.org/10.1016/j.jaci.2021.04.039
Egg D, Rump IC, Mitsuiki N, Rojas-Restrepo J, Maccari ME, Schwab C, Gabrysch A, Warnatz K, Goldacker S, Patiño V, Wolff D, Okada S, Hayakawa S, Shikama Y, Kanda K, Imai K, Sotomatsu M, Kuwashima M, Kamiya T, Morio T, Matsumoto K, Mori T, Yoshimoto Y, Dybedal I, Kanariou M, Kucuk ZY, Chapdelaine H, Petruzelkova L, Lorenz HM, Sullivan KE, Heimall J, Moutschen M, Litzman J, Recher M, Albert MH, Hauck F, Seneviratne S, Pachlopnik Schmid J, Kolios A, Unglik G, Klemann C, Snapper S, Giulino-Roth L, Svaton M, Platt CD, Hambleton S, Neth O, Gosse G, Reinsch S, Holzinger D, Kim YJ, Bakhtiar S, Atschekzei F, Schmidt R, Sogkas G, Chandrakasan S, Rae W, Derfalvi B, Marquart HV, Ozen A, Kiykim A, Karakoc-Aydiner E, Králíčková P, de Bree G, Kiritsi D, Seidel MG, Kobbe R, Dantzer J, Alsina L, Armangue T, Lougaris V, Agyeman P, Nyström S, Buchbinder D, Arkwright PD, Grimbacher B. Therapeutic options for CTLA-4 insufficiency. J Allergy Clin Immunol. 2021 Jun 07; doi: 10.1016/j.jaci.2021.04.039. Epub 2021 Jun 07. PMID: 34111452.
Copy Download .nbib Format: NLM
Altered Spectrum of Lymphoid Neoplasms in a Single-Center Cohort of Common Variable Immunodeficiency with Immune Dysregulation.

Journal of clinical immunology

Wehr C, Houet L, Unger S, Kindle G, Goldacker S, Grimbacher B, Caballero Garcia de Oteyza A, Marks R, Pfeifer D, Nieters A, Proietti M, Warnatz K, Schmitt-Graeff A.
PMID: 33876323
J Clin Immunol. 2021 Aug;41(6):1250-1265. doi: 10.1007/s10875-021-01016-4. Epub 2021 Apr 19.

PURPOSE: Common variable immune deficiency (CVID) confers an increased risk of lymphoid neoplasms, but reports describing the precise WHO specification of the lymphoma subtypes and their immunological environment are lacking. We therefore classified lymphomas-occurring in a cohort of 21...

Cite
Wehr C, Houet L, Unger S, et al. Altered Spectrum of Lymphoid Neoplasms in a Single-Center Cohort of Common Variable Immunodeficiency with Immune Dysregulation. J Clin Immunol. 2021;41(6):1250-1265doi: 10.1007/s10875-021-01016-4.
Wehr, C., Houet, L., Unger, S., Kindle, G., Goldacker, S., Grimbacher, B., Caballero Garcia de Oteyza, A., Marks, R., Pfeifer, D., Nieters, A., Proietti, M., Warnatz, K., & Schmitt-Graeff, A. (2021). Altered Spectrum of Lymphoid Neoplasms in a Single-Center Cohort of Common Variable Immunodeficiency with Immune Dysregulation. Journal of clinical immunology, 41(6), 1250-1265. https://doi.org/10.1007/s10875-021-01016-4
Wehr, Claudia, et al. "Altered Spectrum of Lymphoid Neoplasms in a Single-Center Cohort of Common Variable Immunodeficiency with Immune Dysregulation." Journal of clinical immunology vol. 41,6 (2021): 1250-1265. doi: https://doi.org/10.1007/s10875-021-01016-4
Wehr C, Houet L, Unger S, Kindle G, Goldacker S, Grimbacher B, Caballero Garcia de Oteyza A, Marks R, Pfeifer D, Nieters A, Proietti M, Warnatz K, Schmitt-Graeff A. Altered Spectrum of Lymphoid Neoplasms in a Single-Center Cohort of Common Variable Immunodeficiency with Immune Dysregulation. J Clin Immunol. 2021 Aug;41(6):1250-1265. doi: 10.1007/s10875-021-01016-4. Epub 2021 Apr 19. PMID: 33876323; PMCID: PMC8310845.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 78 entries